XR stands for extended reality. Basically, it's an umbrella term covering the VR (virtual reality), AR (augmented reality), and MR (mixed reality) technologies. All three are already involved or will be involved in healthcare. In the very near future, you will be able to “swipe” between all three within an application. Different combinations of the technologies will be used to provide specific health benefits, eventually all within a single platform.
It is sometimes hard to explain to people
Read More
Autism
CentralReach Acquires Applied Behavior Analysis Therapy Software Pathfinder Health Innovations
CentralReach, a provider of EHR and practice management solutions that enable Applied Behavior Analysis (ABA) for therapy has acquired Pathfinder Health Innovations (PHI), a practice management and data collection software solution designed for small to medium-sized (SMB) businesses. The acquisition increases CentralReach’s market share and is expected to provide SMB organizations with a quick-start and easy-to-use solution to gain immediate operational efficiencies.Founded in 2010, Pathfinder
Read More
Cognoa Awarded FDA Breakthrough Designations for Diagnostic and Digital Therapeutic Devices for Autism
Cognoa, a digital health company focused on behavioral health for children, today announced FDA Breakthrough designations for it's first diagnostic and therapeutic devices to identify and treat autism. This is the foundation for its AI-based digital precision health to support the developmental and behavioral health of children, combining diagnostics and therapeutics into one platform. This signifies a big step in the company’s expansion into therapeutics.FDA Breakthrough Devices Program
Read More
Cognoa Lands $11.6M for Machine Learning App to Advance Diagnosis of Autism
Cognoa, a Palo Alto, CA-based digital health startup has raised $11.6 million in funding led by existing investor Morningside to advance earlier diagnosis of development delays in children. The company plans to utilize the funding to advance Cognoa's machine-learning-based technology; support additional clinical validation and the U.S. Food and Drug Administration (FDA) submissions and approvals process; and expand commercialization with employers, payers and clinicians. Cognoa has raised a
Read More
